Structural Heart Imaging Market is estimated to be valued at USD 11,240.0 Mn in 2026 and is expected to reach USD 18,470.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.
| Report Coverage |
Report Details |
| Base Year: |
2025 |
Market Size in 2026: |
USD 11,240.0 Mn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: |
7.40% |
2033 Value Projection: |
USD 18,470.0 Mn |
The global structural heart imaging market is a fast-growing segment of cardiovascular diagnostics that includes echocardiography, cardiac MRI, CT, fluoroscopy and intracardiac imaging methods used to visualize and assess structural abnormalities of the heart such as valvular disease and congenital heart disease. These imaging modalities provide detailed anatomical and functional information needed for accurate diagnosis and procedural planning.
The market is moving towards integration with catheterization laboratories, cardiac surgery suites and cardiology centers which helps in diagnosis, treatment plan, real-time procedural guidance and post-procedural assessment. Increasing adoption of minimally invasive structural heart interventions further drives the demand for sophisticated, high-resolution and multimodal cardiac imaging technologies.
Market Dynamics
The global structural heart imaging market is driven by the rising prevalence of structural heart diseases and the increasing adoption of minimally invasive techniques such as TAVR and TMVR, which require precise imaging for diagnosis, procedural planning, and real-time guidance. Technological advancements including 3D/4D echocardiography, cardiac CT, AI-assisted image analysis, and fusion imaging are enhancing visualization and procedural efficacy.
However, the growth of structural heart imaging market is limited by factors such as high capital and equipment costs, limited access to specialized imaging expertise, regulatory requirements and concerns around radiation exposure particularly in emerging markets. Nevertheless, significant opportunities exist in AI-enabled automated image analysis, advanced cardiac MRI and portable or point-of-care imaging, which can improve access and enhance workflow efficiency.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global structural heart imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Siemens Healthineers, GE HealthCare, Koninklijke Philips N.V., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Abbott Laboratories, Terumo Corporation, Shanghai United Imaging Healthcare, Samsung Medison Co., Ltd., and Boston Scientific Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global structural heart imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global structural heart imaging market
Market Segmentation
- Imaging Modality Insights (Revenue, USD Mn, 2021 - 2033)
- Echocardiography
- Angiography
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Nuclear Imaging
- Others
- Procedure Insights (Revenue, USD Mn, 2021 - 2033)
- Transcatheter Aortic Valve Replacement (TAVR)
- Surgical Aortic Valve Replacement (SAVR)
- Transcatheter Mitral Valve Repair/Replacement
- Left Atrial Appendage Closure (LAAC)
- Tricuspid Valve Repair/Replacement
- Annuloplasty
- Valvuloplasty
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Diagnosis
- Pre-Procedural Planning
- Intra-Procedural Guidance
- Post-Procedural Assessment
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Specialty Cardiac Centers
- Diagnostic Imaging Centers
- Cardiology Clinics
- Ambulatory Surgical Centers
- Catheterization Laboratories
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Siemens Healthineers
- GE HealthCare
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- FUJIFILM Holdings Corporation
- Abbott Laboratories
- Terumo Corporation
- Shanghai United Imaging Healthcare
- Samsung Medison Co., Ltd.
- Boston Scientific Corporation